Short-term delivery of anti-PlGF antibody delays progression of atherosclerotic plaques to vulnerable lesions
Open Access
- 1 December 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 86 (1) , 29-36
Abstract
Placental growth factor (PlGF), a homologue of vascular endothelial growth factor, is a pleiotropic cytokine with a pro-inflammatory activity. Previous gene-inactivation studies revealed that the loss of PlGF delays atherosclerotic lesion development and inhibits macrophage infiltration, but the activity of an anti-PlGF antibody (αPlGF mAb) has not been evaluated yet. We characterized the potential of short-term delivery of αPlGF mAb in inhibiting lesion development in ApoE-deficient mice (apoE−/−) and in CD4:TGFβRIIDN x apoE−/− mice, a more severe atherosclerosis model. Short-term treatment of αPlGF mAb reduces early atherosclerotic plaque size and inflammatory cell infiltration in the lesion. These pharmacological αPlGF mAb results confirm previous genetic evidence that inhibition of PlGF slows down early atherosclerotic lesion development. Furthermore, the phenocopy of genetic and pharmacological loss-of-function strategies underscores that αPlGF acts by selectively neutralizing PlGF.Keywords
This publication has 48 references indexed in Scilit:
- T-Cell Activation Leads to Reduced Collagen Maturation in Atherosclerotic Plaques of Apoe−/− MiceThe American Journal of Pathology, 2009
- Role of Smooth Muscle Cells in the Initiation and Early Progression of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Gene Expression Profiling of Human Decidual Macrophages: Evidence for Immunosuppressive PhenotypePLOS ONE, 2008
- Specific association of increased vascular endothelial growth factor expression and its receptors with macrophage differentiation of HL-60 leukemia cellsBiochemical and Biophysical Research Communications, 2008
- Elevated Placental Growth Factor Levels Are Associated With Adverse Outcomes at Four-Year Follow-Up in Patients With Acute Coronary SyndromesJACC, 2006
- Intracellular pathways triggered by the selective FLT‐1‐agonist placental growth factor in vascular smooth muscle cells exposed to hypoxiaBritish Journal of Pharmacology, 2005
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Bone marrow transplantation abolishes inhibition of arteriogenesis in placenta growth factor (PlGF) –/– miceJournal of Molecular and Cellular Cardiology, 2003
- Stabilization of atherosclerotic plaques: New mechanisms and clinical targetsNature Medicine, 2002
- Expression of vascular endothelial growth factor receptors in smooth muscle cellsJournal of Cellular Physiology, 2001